US Stock MarketDetailed Quotes

PTCT PTC Therapeutics

Watchlist
  • 28.570
  • +3.080+12.08%
Close Apr 26 16:00 ET
  • 28.650
  • +0.080+0.28%
Post 18:44 ET
2.19BMarket Cap-3715P/E (TTM)

PTC Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
-4.66%210.12M
34.20%937.82M
83.41%307.06M
-9.46%196.58M
29.17%213.81M
48.17%220.38M
29.75%698.8M
1.32%167.41M
56.50%217.13M
41.87%165.53M
Operating revenue
-4.66%210.12M
34.20%937.82M
83.41%307.06M
-9.46%196.58M
29.17%213.81M
48.17%220.38M
29.75%698.8M
1.32%167.41M
56.50%217.13M
41.87%165.53M
Cost of revenue
4.21%14.74M
46.57%65.49M
167.31%29.12M
-32.25%9.49M
32.08%12.73M
39.56%14.14M
38.20%44.68M
16.79%10.89M
114.27%14.01M
31.00%9.64M
Gross profit
-5.27%195.38M
33.36%872.34M
77.57%277.94M
-7.89%187.08M
28.99%201.08M
48.80%206.24M
29.21%654.12M
0.40%156.52M
53.64%203.12M
42.60%155.89M
Operating expense
-25.05%240.93M
11.67%1.22B
-13.35%274.82M
9.81%303.75M
22.12%321.72M
35.74%321.45M
24.15%1.09B
25.50%317.18M
28.96%276.6M
27.20%263.45M
Selling and administrative expenses
-15.70%73.27M
2.01%332.54M
-17.72%76.29M
0.96%80.89M
10.71%88.45M
18.62%86.91M
14.08%326M
7.13%92.72M
15.69%80.12M
15.99%79.89M
-General and administrative expense
----
----
----
0.96%80.89M
----
----
----
----
--80.12M
----
Research and development costs
-40.48%116.13M
2.31%666.56M
-35.69%121.35M
-0.76%164.21M
18.19%185.87M
39.30%195.12M
20.49%651.5M
25.93%188.69M
26.46%165.46M
25.33%157.26M
Depreciation amortization depletion
30.74%51.53M
91.01%222.64M
115.79%77.17M
89.05%58.65M
80.26%47.4M
67.92%39.42M
112.88%116.55M
118.87%35.76M
115.69%31.02M
106.21%26.29M
-Depreciation and amortization
30.74%51.53M
91.01%222.64M
115.79%77.17M
89.05%58.65M
80.26%47.4M
67.92%39.42M
112.88%116.55M
118.87%35.76M
115.69%31.02M
106.21%26.29M
Operating profit
60.46%-45.55M
20.58%-349.4M
101.94%3.12M
-58.75%-116.66M
-12.16%-120.64M
-17.30%-115.22M
-17.33%-439.93M
-65.92%-160.66M
10.68%-73.49M
-9.99%-107.56M
Net non-operating interest income expense
-49.41%-40.83M
-42.16%-129.18M
-80.71%-44.28M
-34.87%-28.16M
-33.85%-29.42M
-16.23%-27.33M
-5.64%-90.87M
-8.88%-24.5M
4.23%-20.88M
2.58%-21.98M
Non-operating interest expense
49.41%40.83M
42.16%129.18M
80.71%44.28M
34.87%28.16M
33.85%29.42M
16.23%27.33M
5.64%90.87M
8.88%24.5M
-4.23%20.88M
-2.58%21.98M
Other net income (expense)
-77.62%1.69M
-283.71%-217.53M
-2,455.03%-115.9M
33.72%-21.77M
-356.34%-87.42M
4,974.84%7.56M
1.19%-56.69M
76.47%-4.54M
-11.02%-32.84M
-875.59%-19.16M
Special income (charges)
104.17%100K
-2,941.93%-227.66M
-239.83%-134.86M
-128.30%-1.5M
-684.87%-88.9M
-120.51%-2.4M
-1,596.80%-7.48M
-427.97%-39.68M
149.07%5.3M
2,271.43%15.2M
-Less：Restructuring and merger&acquisition
-104.17%-100K
-393.05%-127.7M
-142.86%-2.7M
128.30%1.5M
-748.03%-128.9M
120.51%2.4M
-5,080.00%-25.9M
152.07%6.3M
-149.07%-5.3M
-2,271.43%-15.2M
-Less:Impairment of capital assets
----
552.41%217.8M
--0
--0
--217.8M
----
--33.38M
--33.38M
--0
--0
-Less:Other special charges
----
--137.56M
----
----
----
----
----
----
----
----
Other non- operating income (expenses)
-84.02%1.59M
120.59%10.13M
-46.05%18.96M
46.87%-20.27M
104.30%1.48M
183.98%9.96M
14.98%-49.21M
212.02%35.15M
-103.07%-38.14M
-1,183.82%-34.36M
Income before tax
37.26%-84.7M
-18.49%-696.11M
17.21%-157.05M
-30.96%-166.59M
-59.71%-237.48M
-10.75%-134.99M
-13.34%-587.49M
-36.86%-189.69M
4.83%-127.21M
-26.14%-148.7M
Income tax
73.34%6.88M
-144.14%-69.51M
93.30%-1.26M
-87.89%-33.62M
-1,237.85%-38.6M
-17.91%3.97M
-611.96%-28.47M
-503.78%-18.8M
-49,602.78%-17.89M
595.08%3.39M
Net income
34.10%-91.58M
-12.09%-626.6M
8.83%-155.79M
-21.64%-132.97M
-30.77%-198.88M
-9.65%-138.96M
-6.70%-559.02M
-19.28%-170.89M
18.19%-109.32M
-28.48%-152.09M
Net income continuous Operations
34.10%-91.58M
-12.09%-626.6M
8.83%-155.79M
-21.64%-132.97M
-30.77%-198.88M
-9.65%-138.96M
-6.70%-559.02M
-19.28%-170.89M
18.19%-109.32M
-28.48%-152.09M
Minority interest income
Net income attributable to the parent company
34.10%-91.58M
-12.09%-626.6M
8.83%-155.79M
-21.64%-132.97M
-30.77%-198.88M
-9.65%-138.96M
-6.70%-559.02M
-19.28%-170.89M
18.19%-109.32M
-28.48%-152.09M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
34.10%-91.58M
-12.09%-626.6M
8.83%-155.79M
-21.64%-132.97M
-30.77%-198.88M
-9.65%-138.96M
-6.70%-559.02M
-19.28%-170.89M
18.19%-109.32M
-28.48%-152.09M
Basic earnings per share
36.17%-1.2
-7.45%-8.37
12.34%-2.06
-15.03%-1.76
-24.88%-2.66
-5.62%-1.88
-4.85%-7.79
-15.76%-2.35
19.05%-1.53
-26.79%-2.13
Diluted earnings per share
36.17%-1.2
-7.45%-8.37
12.34%-2.06
-15.03%-1.76
-24.88%-2.66
-5.62%-1.88
-4.85%-7.79
-15.76%-2.35
19.05%-1.53
-26.79%-2.13
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue -4.66%210.12M34.20%937.82M83.41%307.06M-9.46%196.58M29.17%213.81M48.17%220.38M29.75%698.8M1.32%167.41M56.50%217.13M41.87%165.53M
Operating revenue -4.66%210.12M34.20%937.82M83.41%307.06M-9.46%196.58M29.17%213.81M48.17%220.38M29.75%698.8M1.32%167.41M56.50%217.13M41.87%165.53M
Cost of revenue 4.21%14.74M46.57%65.49M167.31%29.12M-32.25%9.49M32.08%12.73M39.56%14.14M38.20%44.68M16.79%10.89M114.27%14.01M31.00%9.64M
Gross profit -5.27%195.38M33.36%872.34M77.57%277.94M-7.89%187.08M28.99%201.08M48.80%206.24M29.21%654.12M0.40%156.52M53.64%203.12M42.60%155.89M
Operating expense -25.05%240.93M11.67%1.22B-13.35%274.82M9.81%303.75M22.12%321.72M35.74%321.45M24.15%1.09B25.50%317.18M28.96%276.6M27.20%263.45M
Selling and administrative expenses -15.70%73.27M2.01%332.54M-17.72%76.29M0.96%80.89M10.71%88.45M18.62%86.91M14.08%326M7.13%92.72M15.69%80.12M15.99%79.89M
-General and administrative expense ------------0.96%80.89M------------------80.12M----
Research and development costs -40.48%116.13M2.31%666.56M-35.69%121.35M-0.76%164.21M18.19%185.87M39.30%195.12M20.49%651.5M25.93%188.69M26.46%165.46M25.33%157.26M
Depreciation amortization depletion 30.74%51.53M91.01%222.64M115.79%77.17M89.05%58.65M80.26%47.4M67.92%39.42M112.88%116.55M118.87%35.76M115.69%31.02M106.21%26.29M
-Depreciation and amortization 30.74%51.53M91.01%222.64M115.79%77.17M89.05%58.65M80.26%47.4M67.92%39.42M112.88%116.55M118.87%35.76M115.69%31.02M106.21%26.29M
Operating profit 60.46%-45.55M20.58%-349.4M101.94%3.12M-58.75%-116.66M-12.16%-120.64M-17.30%-115.22M-17.33%-439.93M-65.92%-160.66M10.68%-73.49M-9.99%-107.56M
Net non-operating interest income expense -49.41%-40.83M-42.16%-129.18M-80.71%-44.28M-34.87%-28.16M-33.85%-29.42M-16.23%-27.33M-5.64%-90.87M-8.88%-24.5M4.23%-20.88M2.58%-21.98M
Non-operating interest expense 49.41%40.83M42.16%129.18M80.71%44.28M34.87%28.16M33.85%29.42M16.23%27.33M5.64%90.87M8.88%24.5M-4.23%20.88M-2.58%21.98M
Other net income (expense) -77.62%1.69M-283.71%-217.53M-2,455.03%-115.9M33.72%-21.77M-356.34%-87.42M4,974.84%7.56M1.19%-56.69M76.47%-4.54M-11.02%-32.84M-875.59%-19.16M
Special income (charges) 104.17%100K-2,941.93%-227.66M-239.83%-134.86M-128.30%-1.5M-684.87%-88.9M-120.51%-2.4M-1,596.80%-7.48M-427.97%-39.68M149.07%5.3M2,271.43%15.2M
-Less：Restructuring and merger&acquisition -104.17%-100K-393.05%-127.7M-142.86%-2.7M128.30%1.5M-748.03%-128.9M120.51%2.4M-5,080.00%-25.9M152.07%6.3M-149.07%-5.3M-2,271.43%-15.2M
-Less:Impairment of capital assets ----552.41%217.8M--0--0--217.8M------33.38M--33.38M--0--0
-Less:Other special charges ------137.56M--------------------------------
Other non- operating income (expenses) -84.02%1.59M120.59%10.13M-46.05%18.96M46.87%-20.27M104.30%1.48M183.98%9.96M14.98%-49.21M212.02%35.15M-103.07%-38.14M-1,183.82%-34.36M
Income before tax 37.26%-84.7M-18.49%-696.11M17.21%-157.05M-30.96%-166.59M-59.71%-237.48M-10.75%-134.99M-13.34%-587.49M-36.86%-189.69M4.83%-127.21M-26.14%-148.7M
Income tax 73.34%6.88M-144.14%-69.51M93.30%-1.26M-87.89%-33.62M-1,237.85%-38.6M-17.91%3.97M-611.96%-28.47M-503.78%-18.8M-49,602.78%-17.89M595.08%3.39M
Net income 34.10%-91.58M-12.09%-626.6M8.83%-155.79M-21.64%-132.97M-30.77%-198.88M-9.65%-138.96M-6.70%-559.02M-19.28%-170.89M18.19%-109.32M-28.48%-152.09M
Net income continuous Operations 34.10%-91.58M-12.09%-626.6M8.83%-155.79M-21.64%-132.97M-30.77%-198.88M-9.65%-138.96M-6.70%-559.02M-19.28%-170.89M18.19%-109.32M-28.48%-152.09M
Minority interest income
Net income attributable to the parent company 34.10%-91.58M-12.09%-626.6M8.83%-155.79M-21.64%-132.97M-30.77%-198.88M-9.65%-138.96M-6.70%-559.02M-19.28%-170.89M18.19%-109.32M-28.48%-152.09M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 34.10%-91.58M-12.09%-626.6M8.83%-155.79M-21.64%-132.97M-30.77%-198.88M-9.65%-138.96M-6.70%-559.02M-19.28%-170.89M18.19%-109.32M-28.48%-152.09M
Basic earnings per share 36.17%-1.2-7.45%-8.3712.34%-2.06-15.03%-1.76-24.88%-2.66-5.62%-1.88-4.85%-7.79-15.76%-2.3519.05%-1.53-26.79%-2.13
Diluted earnings per share 36.17%-1.2-7.45%-8.3712.34%-2.06-15.03%-1.76-24.88%-2.66-5.62%-1.88-4.85%-7.79-15.76%-2.3519.05%-1.53-26.79%-2.13
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg
Concept Top Gainers Yesterday
Top Gainers Yesterday
Intraday-1.04%